Vaccine used in Azerbaijan is effective against British strain - OFFICIAL
Health
- 18 March, 2021
- 09:02

The CoronoVAC vaccine produced by the Chinese company SinoVac, which is used against coronavirus infection in Azerbaijan, is also effective against new strains, the National Center for Hematology and Transfusion told Report.
501Y.V1 and B.1.1.7 (British version) were found in three samples analyzed by the Sars Cov-2 genome at the Center's Genetic Diagnostic Center.
Azerbaijan started the vaccination process on January 18. Vaccination is performed voluntarily and at state expense. To date, 468,826 people in the country have been vaccinated.
Latest News
21:32
UN: Quake in Afghanistan could affect ‘hundreds of thousands'
Other countries21:15
Dushanbe, Beijing discuss co-op in Central Asia–China format
Other countries21:01
Moody's: Azerbaijan becomes regional leader in renewable energy dev't
Energy20:56
OSCE PA President welcomes decision to close Minsk process
Foreign policy20:49
Claims about hunger strike by Armenian-origin terrorist in Azerbaijani custody are false
Domestic policy20:38
EU donates €1M in humanitarian emergency funding to Afghanistan
Other countries20:25
Moody's: IFIs can help bridge climate finance gaps in Azerbaijan
Finance20:15
Photo
Azerbaijan, Türkiye sign Action Plan on Labor & Social Security for 2026-2027
Foreign policy20:09
Photo